{"abstract":"The National Institute of Diabetes and Digestive and Kidney Disease and National Institute of Dental and Craniofacial Research, institutes of the National Institutes of Health, Department of Health and Human Services, are contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the Australian, Brazilian, Canadian, Chinese, European, Hong Kong, Israeli, Japanese, South Korean, Mexican, Malaysian, New Zealand, Philippines, Singapore, United States, and South African Applications listed in the Supplementary Information section of this notice to MeiraGTx, LLC, located in New York City, New York, USA.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2024/07/29/2024-16594.html","cfr_references":[],"citation":"89 FR 60906","comment_url":null,"comments_close_on":"2024-08-13","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license that are received by the National Institute of Diabetes and Digestive and Kidney Disease's Technology Advancement Office on or before August 13, 2024 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2024-16594","effective_on":null,"end_page":60907,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2024/07/29/2024-16594.xml","html_url":"https://www.federalregister.gov/documents/2024/07/29/2024-16594/prospective-grant-of-an-exclusive-patent-license-adeno-associated-virus-vector-mediated-gene","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2024-16594?publication_date=2024-07-29","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2024-07-29/2024-16594/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":94,"last_updated":"2026-10-24 10:15:05 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-07-29/pdf/2024-16594.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-16594.pdf?1721997926","publication_date":"2024-07-29","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2024/07/29/2024-16594.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2024-07-27T08:11:02Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":60906,"subtype":null,"title":"Prospective Grant of an Exclusive Patent License: Adeno-Associated Virus Vector-Mediated Gene Delivery of Human Aquaporin-1 To Prevent Radiation-Induced Salivary Hypofunction","toc_doc":"Exclusive Patent; Adeno-Associated Virus Vector-Mediated Gene Delivery of Human aquaporin-1 to Prevent Radiation-Induced Salivary Hypofunction","toc_subject":"Licenses; Exemptions, Applications, Amendments, etc.:\n","topics":[],"type":"Notice","volume":89}